Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

Catalent, will Italy do business with anti-obesity drugs?

Summary by Vogon Today
With the acquisition of Catalent by Novo Holdings, parent company of the Danish laboratory Novo Nordisk, famous for its anti-diabetes drugs capable of fighting obesity, Italy, with the Anagni site, would also produce its share. But competitors protest… All the details The Catalent site in Anagni, in the province of Frosinone, already busy in recent years packing anti-Covid vaccines from Pfizer , AstraZeneca, J&J and Moderna, could soon change…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

ObesityObesity
Novo NordiskNovo Nordisk
European UnionEuropean Union
AnagniAnagni
DenmarkDenmark
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal